BCRX

NASDAQStock

BioCryst Pharmaceuticals, Inc.

$8.39-0.10 (-1.18%)

52-Week Range

$6.24

$11.19

Key Stats

Market Cap

1.8B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76

Volume

2.5M

Avg Volume

5.4M

Performance

+22.51%

+10.41%

+8.83%

YTD

+11.73%

+11.14%

+0.72%

-37.83%

Price Chart

ETF Exposure

BCRX is held by 86 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VTWV	Vanguard Russell 2000 Value ETF	0.01%	16,965	$112K	$1.00B	0.06%
HDG	ProShares - Hedge Replication ETF	0.01%	261	$2K	$23.2M	0.95%
VB	Vanguard Small-Cap ETF	0.01%	2,626,260	$17.3M	$169.10B	0.03%
ONEQ	FIDELITY NASDAQ COMPOSITE INDEX ETF	0.01%	78,972	$691K	$9.01B	0.21%
SILX	ETFMG Prime 2x Daily Junior Silver Miners ETF	0.01%	60,450	$444K	$5.5M	0.97%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.01%	9,770	$82K	$1.43B	0.09%
IWV	iShares Russell 3000 ETF	0.00%	71,438	$625K	$17.58B	0.20%
AVUQ	Avantis U.S. Quality ETF	0.00%	623	$5K	$194.3M	0.15%
DFUS	Dimensional - US Equity Market ETF	0.00%	63,031	$552K	$18.80B	0.09%
ESGV	Vanguard ESG U.S. Stock ETF	0.00%	55,750	$367K	$11.90B	0.09%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	321,823	$2.8M	$81.53B	0.03%
SCHB	Schwab U.S. Broad Market ETF	0.00%	139,817	$1.2M	$38.14B	0.03%
VTHR	Vanguard Russell 3000 ETF	0.00%	18,696	$123K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	7,301,480	$48.0M	$2.10T	0.03%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	34,874	$305K	$41.36B	0.17%
DFAT	Dimensional - US Targeted Value ETF	0.00%	8,956	$78K	$12.61B	0.28%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	111	$971	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	128	$1K	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	151	$1K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	126	$1K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	83	$727	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	63	$550	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	28	$244	$9.5M	0.12%
V3AL.L	Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	2,465	$16K	$1.46B	0.24%
VT	Vanguard Total World Stock ETF	0.00%	172,202	$1.1M	$80.60B	0.06%
AVUS	Avantis U.S. Equity ETF	0.00%	1,145	$10K	$11.08B	0.15%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	3,019	$26K	$10.55B	0.12%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	20	$172	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	65	$571	$81.5M	0.10%
LITL	Simplify Piper Sandler US Small-Cap PLUS Income ETF	0.00%	1	$8	$5.9M	0.91%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	5,090	$34K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	5,090	$34K	$6.3M	0.60%
TILT	FlexShares Morningstar U.S. Market Factor Tilt Index Fund	0.00%	459	$4K	$1.90B	0.26%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	5,090	$34K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	5,090	$34K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	5,090	$34K	$3.7M	0.70%

PreviousPage 2 of 2

About BCRX ETF Exposure

BioCryst Pharmaceuticals, Inc. (BCRX) is held by 86 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.8B, BCRX is a widely held institutional stock. The stock currently trades at $8.39. Investors can gain exposure to BCRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BCRX, sorted by portfolio weight.